The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for ...

COUR Pharmaceuticals, a clinical-stage biotechnology company developing first-in-class, disease-modifying therapies designed ...

The blank slate of a new year is a seductive time when it comes to beauty and wellness. Celebrities in the US from Kate ...

Elsharkawy drinks two cups of coffee a day with his liver in mind. “Coffee is an antifibrotic,” he says, which stops scar ...

Tirupati Diagnostics and labs is a shining example of how quality healthcare can be made accessible to underserved ...

While there is ongoing research to develop better tools like biochemical markers to differentiate fibrosis stage in MASH patients, the only standard currently used in MASH clinical studies involves ...

Imphal, Prof. G. Sunil Kumar Sharma, inaugurated two advanced medical devices—a Fibroscan and a Portable Echo Ultrasound machine—at the Department of Medicine, RIMS, Imphal on Tuesday. The event was ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...